AMBRODIL increases mucus production, reduces its viscosity, and facilitates its expulsion from the lungs. It also shows mild anti-inflammatory action.
Recommended for:
Acute bronchitis
Chronic bronchitis and COPD
Tracheitis, laryngotracheitis
Respiratory illnesses with difficult expectoration in adults and children
Treatment of acute and chronic respiratory tract diseases associated with thick mucus: bronchitis, pneumonia, COPD, asthma.
Taken orally after meals; dosage depends on the patient’s age and clinical condition. Duration of use is determined by a healthcare provider.
Hypersensitivity to ambroxol
Active peptic ulcer disease
First trimester of pregnancy
Possible side effects: nausea, abdominal pain, dry mouth, allergic reactions